- Report
- November 2026
- 373 Pages
Global
From €5419EUR$5,850USD£4,522GBP
- Report
- November 2026
- 278 Pages
Global
From €5419EUR$5,850USD£4,522GBP
- Report
- November 2026
- 179 Pages
Global
From €5419EUR$5,850USD£4,522GBP
- Report
- November 2026
- 284 Pages
Global
From €5419EUR$5,850USD£4,522GBP
- Report
- November 2026
- 447 Pages
Global
From €5419EUR$5,850USD£4,522GBP
- Report
- November 2026
- 446 Pages
Global
From €5419EUR$5,850USD£4,522GBP
- Report
- November 2026
- 361 Pages
Global
From €5419EUR$5,850USD£4,522GBP
- Report
- May 2026
- 180 Pages
Global
From €4168EUR$4,500USD£3,479GBP
- Report
- November 2025
- 186 Pages
Global
From €4168EUR$4,500USD£3,479GBP
- Report
- February 2026
- 250 Pages
Global
From €4159EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4159EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4159EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4159EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4159EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4159EUR$4,490USD£3,471GBP
- Report
- October 2026
- 250 Pages
Global
From €4159EUR$4,490USD£3,471GBP
- Report
- July 2026
- 250 Pages
Global
From €4159EUR$4,490USD£3,471GBP
- Report
- May 2026
- 250 Pages
Global
From €4159EUR$4,490USD£3,471GBP
- Report
- April 2026
- 250 Pages
Global
From €4159EUR$4,490USD£3,471GBP
- Report
- April 2026
- 452 Pages
Global
From €4159EUR$4,490USD£3,471GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more